Admission ST-segment elevation in lead aVR as the factor improving complex risk stratification in acute coronary
Filip M Szymański1, Marcin Grabowski, Krzysztof J Filipiak
1First Department of Cardiology, The Medical University of Warsaw, 02-097 Warsaw, Poland. f.szymanski@post.pl
Insights
ST elevation in lead aVR (aVR(+)) on initial ECG is a strong predictor of 30-day mortality in unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) patients. This finding is particularly important for identifying high-risk individuals within low-risk groups.
Area of Science:
- Cardiology
- Clinical Medicine
- Diagnostic Tools
Background:
- Unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) is a critical cardiovascular condition.
- Accurate prognostic markers are essential for risk stratification and patient management.
- The prognostic value of ST elevation in lead aVR (aVR(+)) in UA/NSTEMI requires further elucidation.
Purpose of the Study:
- To analyze the prognostic significance of aVR(+) on admission ECG in UA/NSTEMI patients.
- To evaluate the combined prognostic value of aVR(+) with clinical variables and TIMI risk score.
- To determine if aVR(+) provides additional prognostic information in low- and intermediate-risk UA/NSTEMI patients.
Main Methods:
- Retrospective analysis of admission ECGs in 205 consecutive UA/NSTEMI patients.
- Evaluation of ST elevation in lead aVR (aVR(+)) > 0.5 mm.
- Multivariate analysis to assess independent predictors of 30-day mortality.
- Stratification by clinical factors and Thrombolysis in Myocardial Infarction (TIMI) risk score.
Main Results:
- Admission aVR(+) was a strong and independent predictor of 30-day mortality in UA/NSTEMI.
- Mortality significantly increased with the severity of aVR(+).
- Patients with aVR(+) exhibited higher death rates, even within predefined low-risk clinical groups and TIMI risk score categories.
Conclusions:
- aVR(+) on admission ECG possesses significant prognostic value in UA/NSTEMI.
- aVR(+) offers incremental prognostic information beyond conventional risk factors, especially in low- and intermediate-risk patients.
- Routine assessment of aVR(+) may enhance risk stratification in UA/NSTEMI management.
Abstract:
This study aimed to analyze the prognostic value of the presence of ST elevation in lead aVR [aVR(+)] in initial standard electrocardiogram (ECG) performed on admission in combination with clinical variables and Thrombolysis in Myocardial Infarction (TIMI) risk score for unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI). In 205 consecutive patients with UA/NSTEMI, we retrospectively evaluated admission ECG for aVR(+) of more than 0.5 mm. With the use of multivariate analysis, admission aVR(+) was found to be a strong and independent predictor of 30-day mortality. Mortality also increased with the severity of aVR(+): 2.2%, 10.8%, 13.8%, 22.2%, 50% (P value for trend <.0001). In prespecified low-risk groups by clinical factors, those with aVR(+) had higher death rates than those without aVR(+): 16.1% vs 2.2% (P = .04), 13.9% vs 1.1% (P = .001), 12.4% vs 1.1% (P = .002), 9.6% vs 1.2% (P = .02), and 6.7% vs 0% (P = .05) for patients with negative troponin, heart rate of 110 beats per minute or less, systolic blood pressure greater than 90 mm Hg, Killip I class on admission, and age 70 years or younger, respectively. Patients with aVR(+) compared to patients without aVR(+) had higher death rates in the low- and intermediate-risk groups by TIMI risk score. Our findings suggest that aVR(+) has significant prognostic value in patients with UA/NSTEMI and may provide an additional prognostic value to the conventional cardiovascular risk factor, particularly in patients in the low-risk and intermediate-risk groups.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome V: Nursing Management
